Pulmonary rehabilitation causes a decrease in interleukin-8 and myeloperoxidase levels in sputum of patients with COPD

M. Czerwinski, K. Bogacz, J. Luniewski, A. Tukiendorf, J. Szczegielniak (Opole, Poland)

Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury
Session: Mechanisms of lung injury: COPD, asthma and acute lung injury
Session type: Thematic Poster Session
Number: 3636
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Czerwinski, K. Bogacz, J. Luniewski, A. Tukiendorf, J. Szczegielniak (Opole, Poland). Pulmonary rehabilitation causes a decrease in interleukin-8 and myeloperoxidase levels in sputum of patients with COPD. Eur Respir J 2009; 34: Suppl. 53, 3636

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Change of induced sputum TNF-a and sTNF-R55,75 levels in patients with acute exacerbations of COPD
Source: Annual Congress 2007 - Respiratory pathophysiology
Year: 2007


Decreased levels of myeloperoxidase in induced sputum of COPD patients after oral glucocorticoids treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 404s
Year: 2002

Increased levels of hyaluronan in induced sputum from COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 436s
Year: 2003

Neutrophil elastase and IL-8 assessment in patients with COPD and asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 61s
Year: 2005

Sputum cellularity and IL-8 levels are related to clinical and pulmonary function abnormalities in patients with asbestosis
Source: Eur Respir J 2006; 28: Suppl. 50, 692s
Year: 2006

Neutrophil elastase levels in sputum of patients with different airway diseases: COPD, bronchiectasis and asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 95s
Year: 2002

Induced sputum glutathione levels are decreased in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2001; 18: Suppl. 33, 409s
Year: 2001

Cytokines levels of blood and sputum in COPD exacerbation
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010

Sputum VEGF level increases with treatment of COPD acute exacerbation
Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation
Year: 2012


Time course of sputum and serum interleukin-6 during COPD exacerbations
Source: Eur Respir J 2005; 26: Suppl. 49, 464s
Year: 2005

Release of IL-1b, IL-6 and TNF-a after pulmonary rehabilitation in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Physiological response to exercise performance
Year: 2008

Increased levels of osteopontin in sputum supernatant in patients with COPD
Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers
Year: 2012


Increased neutrophil adhesion in bronchial biopsies from patients with severe COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 136s
Year: 2007

Effects of endurance training on pulmonary and systemic levels of interleukin-8 in patients with stable COPD
Source: Annual Congress 2012 - COPD treatment and varia
Year: 2012


Il-6 levels in sera and induced sputum of COPD patients during exacerbations and stable period
Source: Eur Respir J 2005; 26: Suppl. 49, 284s
Year: 2005

Corticosteroid increased apoptosis of airway sputum macrophages from patients with COPD and emphysema
Source: Eur Respir J 2001; 18: Suppl. 33, 337s
Year: 2001

Elevated TNF-α and interleukin-6 levels in breath condensate and serum of patients with non-CF bronchiectasis: comparison to COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 227s
Year: 2005

Cytokines and MMP-9 level in serum and induced sputum of patients with suspicion of occupational COPD
Source: International Congress 2016 – Occupational and environmental exposures and biomarkers: human studies, animal data, and in vitro methods
Year: 2016

Levels of CC-chemokines (MCP-1, MIP-1α, MIP-1β) in induced sputum of patients with chronic obstructive pulmonary disease and patients with chronic bronchitis
Source: Eur Respir J 2001; 18: Suppl. 33, 194s
Year: 2001

The effect of inhaled corticosteroids on bronchoalveolar lavage interleukin-8 levels and cell percentage in stable chronic obstructive pulmonary disease patients
Source: Eur Respir J 2001; 18: Suppl. 33, 212s
Year: 2001